Arteris (NASDAQ:AIP) Stock: Insider K Charles Janac Sells 11,452 Shares

Arteris, Inc. (NASDAQ:AIP – Get Free Report) CEO K Janac sold 11,452 shares of the company’s stock in a transaction on Monday, October 5th. The stock was sold at an average price of $24.27, for a total value of $277,940.04. Following the transaction, the chief executive officer owned 154,337 shares in the company, valued at $3,745,758.99. This trade represents a 6.91% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

K Charles Janac also recently made the following trade(s):

  • On Friday, October 2nd, K Janac sold 9,359 shares of Arteris stock. The shares were sold at an average price of $24.64, for a total value of $230,605.76.
  • On Thursday, October 1st, K Janac sold 100,000 shares of Arteris stock. The shares were sold at an average price of $23.82, for a total value of $2,382,000.00.
  • On Tuesday, September 1st, K Janac sold 100,000 shares of Arteris stock. The stock was sold at an average price of $20.75, for a total value of $2,075,000.00.
  • On Tuesday, August 4th, K Janac sold 26,106 shares of Arteris stock. The shares were sold at an average price of $31.97, for a total value of $834,608.82.
  • On Monday, August 3rd, K Janac sold 73,894 shares of Arteris stock. The stock was sold at an average price of $30.00, for a total transaction of $2,216,820.00.

Arteris Trading Up 0.7%

NASDAQ:AIP traded up $0.16 on Tuesday, reaching $24.13. 476,272 shares of the company’s stock were exchanged, compared to its average volume of 728,847. The firm has a market capitalization of $1.19 billion, a price-to-earnings ratio of -27.74 and a beta of 1.90. Arteris, Inc. has a 52-week low of $12.06 and a 52-week high of $50.26. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.03. The business has a fifty day moving average of $24.73 and a 200-day moving average of $28.61.

Arteris (NASDAQ:AIP – Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.04) by ($0.06). Arteris had a negative net margin of 46.70% and a negative return on equity of 295.96%. The business had revenue of $24.13 million during the quarter, compared to analysts’ expectations of $23.48 million. As a group, analysts expect that Arteris, Inc. will post -0.68 earnings per share for the current year.

Hedge Funds Weigh In On Arteris

Institutional investors and hedge funds have recently modified their holdings of the company. BlackRock Inc. purchased a new position in Arteris in the second quarter valued at $160,129,000. Needham Investment Management LLC boosted its position in shares of Arteris by 2.6% during the 4th quarter. Needham Investment Management LLC now owns 3,411,500 shares of the company’s stock worth $52,878,000 after acquiring an additional 86,500 shares in the last quarter. Wellington Management Group LLP boosted its position in shares of Arteris by 0.4% during the 2nd quarter. Wellington Management Group LLP now owns 500,200 shares of the company’s stock worth $24,305,000 after acquiring an additional 1,897 shares in the last quarter. Granahan Investment Management LLC boosted its position in shares of Arteris by 201.0% during the 1st quarter. Granahan Investment Management LLC now owns 713,077 shares of the company’s stock worth $11,723,000 after acquiring an additional 476,181 shares in the last quarter. Finally, Algert Global LLC purchased a new position in shares of Arteris in the 2nd quarter valued at about $11,602,000. Institutional investors and hedge funds own 64.36% of the company’s stock.

Analyst Upgrades and Downgrades

AIP has been the topic of several analyst reports. Oppenheimer began coverage on Arteris in a research note on Thursday, July 16th. They issued an “outperform” rating and a $40.00 price objective on the stock. Rosenblatt Securities reissued a “buy” rating and set a $38.00 target price on shares of Arteris in a research note on Friday, August 7th. Weiss Ratings upgraded Arteris from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, August 21st. Jefferies Financial Group upgraded Arteris from a “hold” rating to a “buy” rating and lifted their price objective for the company from $35.00 to $50.00 in a research note on Friday, August 7th. Finally, Roth Capital started coverage on Arteris in a research report on Tuesday, August 4th. They set a “buy” rating and a $40.00 price objective for the company. Six investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $39.43.

Check Out Our Latest Report on AIP

Key Headlines Impacting Arteris

Here are the key news stories impacting Arteris this week:

  • Positive Sentiment: Arteris won an additional $3.3 million through the Trusted and Assured Microelectronics program to expand its third-party semiconductor IP security-assurance efforts. The company is collaborating with BAE Systems and SiFive, potentially strengthening its position in defense-related and trusted-chip supply chains. Arteris funding announcement
  • Neutral Sentiment: CEO K. Charles Janac and Vice President Paul Alpern sold shares, but the filings state the transactions were made to cover tax withholding obligations related to vested equity awards. Because these were tax-related sales rather than clearly discretionary trades, they provide a limited signal about management’s outlook. SEC filing for executive share sales
  • Negative Sentiment: Major shareholder Bayview Legacy LLC sold 100,000 shares for approximately $2.38 million, reducing its ownership by 1.22%. The filing did not cite tax withholding as the reason, so the sale could create modest supply pressure and raise concerns about near-term shareholder confidence. SEC filing for Bayview Legacy share sale

Arteris Company Profile

(Get Free Report)

Arteris, Inc is a semiconductor intellectual property (IP) company that develops technologies used in the design of system-on-chip (SoC) devices. Its products help semiconductor and electronics companies connect, manage and protect the various processing, memory and other functional components integrated into complex chips.

The company’s portfolio includes network-on-chip (NoC) interconnect IP, which supports communication among different elements within an SoC, as well as cache-coherent interconnect, system IP and related design technologies.

Featured Articles

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.